Investigations in this area are still ongoing
Without this information, peptide therapy is guesswork
This review synthesizes current knowledge on HT's epidemiology, pathogenesis, and recent therapeutic advances, highlighting the complex interplay of genetic, environmental, and immunological factors that contribute to the disease's progression and management
Melanocortin-receptor peptides (Melanotan I / Afamelanotide, Melanotan II, PT-141 / Bremelanotide): synthetic analogues of alpha-MSH studied for their activity at melanocortin receptors (MC1R, MC4R and related subtypes) in models of pigmentation biology and central melanocortin signalling
However, the evidence for PRP is somewhat stronger, and it has been used more extensively in clinical practice